JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A4359 Brinzolamide

Summary: CA II inhibitor

insoluble in H2O; ≥15.05 mg/mL
A4365 Lovastatin
2 Citation

Target: HMG-CoA Reductases

Summary: HMG-CoA reductase inhibitor
A4370 Moclobemide (Ro 111163)

Summary: Reversible inhibitor of MAO-A
A4372 URB597
7 Citation

Summary: FAAH inhibitor,potent and selective

insoluble in H2O; ≥16.9 mg/mL
A4373 NLG919
1 Citation

Summary: Potent IDO pathway inhibitor

insoluble in H2O; insoluble in EtOH; ≥47.7 mg/mL
A4377 Evacetrapib (LY2484595)

Target: CETP

Summary: CETP inhibitor,potent and selective

≥32.1 mg/mL
A4381 FK866 (APO866)
12 Citation

Target: Nampt

Summary: NAMPT inhibitor, non-competitive, highly specific

insoluble in H2O; ≥19.6 mg/mL
A1138 Glycoprotein B (485-492)

Summary: Invovled in HSV viral cell entry

≥92.2 mg/mL
A1934 Oprozomib (ONX-0912)
5 Citation

Summary: Proteasome inhibitor

≥26.6 mg/mL
A3115 24, 25-Dihydroxy VD3
2 Citation

Summary: Vitamin D analogue

Soluble in DMSO